Tharos Laboratories, Inc. Will Offer Pharmaceutical Grade, Botanical Based Products, Backed by Scientific Evidence


FOXBORO, Mass., Feb. 11, 2004 (PRIMEZONE) -- Nikos Linardakis, M.D., C.E.O. and President of Tharos Laboratories, Inc. (TLI), plans to highlight his science-driven company by emphasizing the Company's philosophy: "Strength from Nature, Endorsed by Science." Tharos will satisfy the needs of various companies, including nutritional, fine chemical, animal feed and cosmetic, by supplying standardized phytochemical ingredients that will allow its customers to offer superior bioactive end products to the public.

Dr. Linardakis states, "Our goal is to offer a pharmaceutical grade, standardized product, backed by clinical trials suitable for publication. We guarantee our listed ingredients are pure, and the measured dosage on the label will be found in the product. Furthermore, our customers will be receiving the specific quantity of a botanical active ingredient that has shown to be effective in scientific studies."

Tharos will develop a portfolio of unique compounds, and novel therapeutic products from botanical sources. Tharos Laboratories, Inc. will incorporate the following characteristics in all of its products:


 1. Specific phytochemical groups
 2. Effective dosage and nutrient content
 3. Standardized ingredients
 4. Pharmaceutical grade products
 5. Evidenced with clinical studies 

Tharos Laboratories, Inc. is a pharmaceutical-grade and food-grade product development company. The focus of the Company is to develop naturally occurring compounds, and conduct laboratory and clinical studies to confirm their value for health and wellness.

Tharos Laboratories is a private company, which anticipates going public in the future; for additional information please contact John Leo. Email: John@TharosLabs.com Tel: (201) 200-9394.

If you would like more information about Tharos Laboratories, Inc., its Products and Science, please contact Nikos Linardakis, MD. Email: Nikos@TharosLabs.com Tel: (508) 982-3839.


            

Contact Data